ZNTL logo

Zentalis Pharmaceuticals, Inc. (ZNTL)

Profile

Full Name

Zentalis Pharmaceuticals, Inc.

Ticker

NASDAQ: ZNTL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 3, 2020

Indexes

Not included

Website

https://zentalis.com

Employees

166

Key Details

Price

$1.34(-2.90%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$67.42M

Annual EPS

-$2.33(+47.87% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.34
    ZNTL price is $1.34

    30-Day Relative Volume

    0.39
    ZNTL 30-day relative volume is 0.39

    Price Performance

    Price Most recent change

    -2.9%
    ZNTL price was down -2.9% on Aug 1, 2025

    Price YTD change

    -55.78%
    ZNTL price is down -55.78% since January 1st

    Price 1-year change

    -64.74%
    ZNTL price is down -64.74% year-on-year

    Price 3-year change

    -95.35%
    ZNTL price is down -95.35% over the past 3 years

    Price Range

    Price All-time high

    $87.19
    ZNTL price is currently -98.46% below its historical high of $87.19

    Price 3-year low

    $1.01
    ZNTL price is currently +32.67% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $96.42M
    ZNTL market capitalization is $96.42 million

    Market cap 3-year change

    -94.13%
    ZNTL market capitalization is down -94.13% over the past 3 years

    Market cap All-time high

    $3.83B
    ZNTL market capitalization is currently -97.48% below its historical high of $3.83 billion

    Market cap sector rank

    43.27%
    ZNTL market capitalization is higher than 43.27% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.19%
    ZNTL shares outstanding is up +1.19% year-on-year

    Shares Outstanding 3-Year Change

    +26.3%
    ZNTL shares outstanding is up +26.3% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.67
    ZNTL beta is 1.67

    200-day SMA

    $2.12
    ZNTL price is currently -36.73% below its 200-day simple moving average

    50-day SMA

    $1.35
    ZNTL price is currently -0.89% below its 50-day simple moving average

    RSI

    47.07
    ZNTL 14-day relative strength index is 47.07

    Volume

    0.39
    ZNTL 30-day relative volume is 0.39

    ATR

    $0.09
    ZNTL average true range is $0.09

    10-day Historical Volatility

    53.72%
    ZNTL 10-day historical volatility is 53.72%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $67.42M
    ZNTL annual revenue is $67.42 million

    Revenue Analysts estimate

    -
    ZNTL annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    ZNTL annual revenue 1-year change is unknown

    Revenue Sector rank

    51.37%
    ZNTL annual revenue is higher than 51.37% of companies in Healthcare sector

    EPS

    EPS

    -$2.33
    ZNTL annual earnings per share is -$2.33

    EPS Analysts estimate

    -$2.21
    ZNTL annual earnings per share is currently +5.43% higher than the consensus analysts' forecast

    EPS 1-year change

    +47.87%
    ZNTL annual earnings per share is up +47.87% year-on-year

    EPS Sector rank

    36.86%
    ZNTL annual earnings per share is higher than 36.86% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ZNTL annual gross profit value is unknown

    Gross margin

    -
    ZNTL annual gross profit margin value is unknown

    Operating profit

    -$187.46M
    ZNTL annual operating income is -$187.46 million

    Operating margin

    -278.02%
    ZNTL annual operating profit margin is -278.02%

    Net income

    -$165.84M
    ZNTL annual net profit is -$165.84 million

    Net margin

    -245.96%
    ZNTL annual net profit margin is -245.96%

    Expenses

    Total expenses

    $254.88M
    ZNTL annual total expenses is $254.88 million

    Operating expenses

    $254.88M
    ZNTL annual total operating expenses is $254.88 million

    Cost of goods sold

    -
    ZNTL annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $87.11M
    ZNTL annual SGA is $87.11 million

    Depreciation and amortization

    $1.29M
    ZNTL annual depreciation & amortization is $1.29 million

    Interest expense

    -
    ZNTL annual interest expense value is unknown

    Income tax

    $177.00K
    ZNTL annual income tax is $177.00 thousand

    EBIT & EBITDA

    EBIT

    -$187.46M
    ZNTL annual earnings before interest & taxes is -$187.46 million

    EBITDA

    -$186.17M
    ZNTL annual EBITDA is -$186.17 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $430.34M
    ZNTL annual total assets is $430.34 million

    Non current assets

    $44.27M
    ZNTL annual long term assets is $44.27 million

    Current assets

    $386.07M
    ZNTL annual total current assets is $386.07 million

    Cash and cash equivalents

    $33.90M
    ZNTL annual cash & cash equivalents is $33.90 million

    Accounts receivable

    -
    ZNTL annual accounts receivable value is unknown

    Inventory

    -
    ZNTL annual inventory value is unknown

    Liabilities

    Total liabilities

    $93.15M
    ZNTL annual total liabilities is $93.15 million

    Long term liabilities

    $40.43M
    ZNTL annual total long term liabilities is $40.43 million

    Current liabilities

    $52.73M
    ZNTL annual total current liabilities is $52.73 million

    Accounts payable

    $7.44M
    ZNTL annual accounts payable is $7.44 million

    Debt

    Total debt

    $39.58M
    ZNTL annual total debt is $39.58 million

    Total debt 1-year change

    -8.28%
    ZNTL annual total debt is down -8.28% year-on-year

    Long term debt

    $39.58M
    ZNTL annual long term debt is $39.58 million

    Short term debt

    -
    ZNTL annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $337.19M
    ZNTL annual stockholders equity is $337.19 million

    Book value

    $337.19M
    ZNTL annual book value is $337.19 million

    Retained earnings

    -$1.05B
    ZNTL annual retained earnings is -$1.05 billion

    Working capital

    $333.34M
    ZNTL annual working capital is $333.34 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$170.86M
    ZNTL annual cash flow from operations is -$170.86 million

    Cash from operations 1-year change

    +17.79%
    ZNTL annual cash flow from operations is up +17.79% year-on-year

    Cash from investing

    $176.56M
    ZNTL annual cash flow from investing activities is $176.56 million

    Cash from investing 1-year change

    +497.14%
    ZNTL annual cash flow from investing activities is up +497.14% year-on-year

    Cash from financing

    $108.00K
    ZNTL annual cash flow from financing activities is $108.00 thousand

    Cash from financing 1-year change

    -99.95%
    ZNTL annual cash flow from financing activities is down -99.95% year-on-year

    CAPEX

    CAPEX

    $221.00K
    ZNTL annual capital expenditures is $221.00 thousand

    CAPEX 1-year change

    -62.09%
    ZNTL annual capital expenditures is down -62.09% year-on-year

    Free Cash Flow

    Free cash flow

    -$171.08M
    ZNTL annual free cash flow is -$171.08 million

    Free cash flow 1-year change

    +17.91%
    ZNTL annual free cash flow is up +17.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ZNTL annual gross profit margin value is unknown

    Operating margin

    -278.02%
    ZNTL annual operating profit margin is -278.02%

    Net margin

    -245.96%
    ZNTL annual net profit margin is -245.96%

    ROA & ROE

    ROA

    -33.77%
    ZNTL annual return on assets is -33.77%

    ROE

    -42.82%
    ZNTL annual return on equity is -42.82%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ZNTL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ZNTL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.33
    ZNTL price to book ratio is 0.33

    PB ratio Sector rank

    21.41%
    ZNTL price to book ratio is higher than 21.41% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ZNTL price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ZNTL price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $93.14M
    ZNTL enterprise value is $93.14 million

    Enterprise value Sector rank

    44.35%
    ZNTL enterprise value is higher than 44.35% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.47
    ZNTL EV/EBITDA is -0.47

    EV/EBITDA Sector rank

    55.88%
    ZNTL EV/EBITDA is higher than 55.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.32
    ZNTL annual current ratio is 7.32

    Quick ratio

    -
    ZNTL annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ZNTL annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ZNTL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ZNTL piotroski f-score value is unknown

    Altman Z-Score

    -3.16
    ZNTL altman z-score is -3.16

    Analyst ratings

    Recent major analysts updates

    May 15, 25 Wedbush
    Neutral
    May 15, 25 HC Wainwright & Co.
    Buy
    Mar 28, 25 Wedbush
    Neutral
    Mar 27, 25 HC Wainwright & Co.
    Buy
    Mar 17, 25 HC Wainwright & Co.
    Buy
    Jan 30, 25 Wells Fargo
    Equal-Weight
    Jan 29, 25 HC Wainwright & Co.
    Buy
    Jan 28, 25 UBS
    Neutral
    Nov 15, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 Guggenheim
    Buy

    Institutional Ownership

    Screeners with ZNTL included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Zentalis Pharmaceuticals, Inc.?
    • Does Zentalis Pharmaceuticals, Inc. pay dividends?
    • What sector is Zentalis Pharmaceuticals, Inc. in?
    • What industry is Zentalis Pharmaceuticals, Inc. in?
    • What country is Zentalis Pharmaceuticals, Inc. based in?
    • When did Zentalis Pharmaceuticals, Inc. go public?
    • Is Zentalis Pharmaceuticals, Inc. in the S&P 500?
    • Is Zentalis Pharmaceuticals, Inc. in the NASDAQ 100?
    • Is Zentalis Pharmaceuticals, Inc. in the Dow Jones?
    • When was Zentalis Pharmaceuticals, Inc.'s last earnings report?
    • When does Zentalis Pharmaceuticals, Inc. report earnings?

    What is the ticker symbol for Zentalis Pharmaceuticals, Inc.?

    The ticker symbol for Zentalis Pharmaceuticals, Inc. is NASDAQ:ZNTL

    Does Zentalis Pharmaceuticals, Inc. pay dividends?

    No, Zentalis Pharmaceuticals, Inc. does not pay dividends

    What sector is Zentalis Pharmaceuticals, Inc. in?

    Zentalis Pharmaceuticals, Inc. is in the Healthcare sector

    What industry is Zentalis Pharmaceuticals, Inc. in?

    Zentalis Pharmaceuticals, Inc. is in the Biotechnology industry

    What country is Zentalis Pharmaceuticals, Inc. based in?

    Zentalis Pharmaceuticals, Inc. is headquartered in United States

    When did Zentalis Pharmaceuticals, Inc. go public?

    Zentalis Pharmaceuticals, Inc.'s initial public offering (IPO) was on April 3, 2020

    Is Zentalis Pharmaceuticals, Inc. in the S&P 500?

    No, Zentalis Pharmaceuticals, Inc. is not included in the S&P 500 index

    Is Zentalis Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Zentalis Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

    Is Zentalis Pharmaceuticals, Inc. in the Dow Jones?

    No, Zentalis Pharmaceuticals, Inc. is not included in the Dow Jones index

    When was Zentalis Pharmaceuticals, Inc.'s last earnings report?

    Zentalis Pharmaceuticals, Inc.'s most recent earnings report was on May 14, 2025

    When does Zentalis Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Zentalis Pharmaceuticals, Inc. is August 8, 2025
    On this page